Literature DB >> 10623804

Effects of Src homology domain 2 (SH2)-containing inositol phosphatase (SHIP), SH2-containing phosphotyrosine phosphatase (SHP)-1, and SHP-2 SH2 decoy proteins on Fc gamma RIIB1-effector interactions and inhibitory functions.

K Nakamura1, A Brauweiler, J C Cambier.   

Abstract

Coaggregation of Fc gamma RIIB1 with B cell Ag receptors (BCR) leads to inhibition of BCR-mediated signaling via recruitment of Src homology domain 2 (SH2)-containing phosphatases. In vitro peptide binding experiments using phosphotyrosine-containing sequences derived from the immunoreceptor tyrosine-based inhibitory motif (ITIM) known to mediate Fc gamma RIIB1 effects suggest that the receptor uses SH2-containing inositol phosphatase (SHIP) and SH2-containing phosphotyrosine phosphatase (SHP)-1, as well as SHP-2 as effectors. In contrast, coimmunoprecipitation studies of receptor-effector associations suggest that the predominant Fc gamma RIIB1 effector protein is SHIP. However, biologically significant interactions may be lost in such studies if reactants' dissociation rates (Kd) are high. Thus, it is unclear to what extent these assays reflect the relative recruitment of SHIP, SHP-1, and SHP-2 to the receptor in vivo. As an alternative approach to this question, we have studied the effects of ectopically expressed SHIP, SHP-1, or SHP-2 SH2-containing decoy proteins on Fc gamma RIIB1 signaling. Results demonstrate the SHIP is the predominant intracellular ligand for the phosphorylated Fc gamma RIIB1 ITIM, although the SHP-2 decoy exhibits some ability to bind Fc gamma RIIB1 and block Fc receptor function. The SHIP SH2, while not affecting Fc gamma RIIB1 tyrosyl phosphorylation, blocks receptor-mediated recruitment of SHIP, SHIP phosphorylation, recruitment of p52 Shc, phosphatidylinositol 3,4,5-trisphosphate hydrolysis, inhibition of mitogen-activated protein kinase activation, and, albeit more modestly, Fc gamma RIIB1 inhibition of Ca2+ mobilization. Taken together, results implicate ITIM interactions with SHIP as a major mechanism of Fc gamma RIIB1-mediated inhibitory signaling.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10623804     DOI: 10.4049/jimmunol.164.2.631

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  Defining the parameters necessary for T-cell recognition of ligands that vary in potency.

Authors:  Neely E Kilgore; Mandy L Ford; Carrie D Margot; Daniel S Jones; Peter Reichardt; Brian D Evavold
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

2.  C-reactive protein inhibits insulin activation of endothelial nitric oxide synthase via the immunoreceptor tyrosine-based inhibition motif of FcgammaRIIB and SHIP-1.

Authors:  Keiji Tanigaki; Chieko Mineo; Ivan S Yuhanna; Ken L Chambliss; Michael J Quon; Ezio Bonvini; Philip W Shaul
Journal:  Circ Res       Date:  2009-05-07       Impact factor: 17.367

3.  The inositol 5-phosphatase SHIP-1 and adaptors Dok-1 and 2 play central roles in CD4-mediated inhibitory signaling.

Authors:  Paul M Waterman; Susanne Marschner; Erin Brandl; John C Cambier
Journal:  Immunol Lett       Date:  2012-02-24       Impact factor: 3.685

Review 4.  DAP12 and KAP10 (DAP10)-novel transmembrane adapter proteins of the CD3zeta family.

Authors:  M J Wilson; J A Lindquist; J Trowsdale
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

Review 5.  Fc receptors and their role in immune regulation and autoimmunity.

Authors:  Toshiyuki Takai
Journal:  J Clin Immunol       Date:  2005-01       Impact factor: 8.317

6.  Toll-like receptor 2 ligands regulate monocyte Fcγ receptor expression and function.

Authors:  Prexy Shah; Kavin Fatehchand; Hemal Patel; Huiqing Fang; Steven E Justiniano; Xiaokui Mo; David Jarjoura; Susheela Tridandapani; Jonathan P Butchar
Journal:  J Biol Chem       Date:  2013-03-15       Impact factor: 5.157

7.  MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia.

Authors:  Bing Cui; Liguang Chen; Suping Zhang; Marek Mraz; Jessie-F Fecteau; Jian Yu; Emanuela M Ghia; Ling Zhang; Lei Bao; Laura Z Rassenti; Karen Messer; George A Calin; Carlo M Croce; Thomas J Kipps
Journal:  Blood       Date:  2014-06-09       Impact factor: 22.113

Review 8.  Regulation of hematopoietic cell function by inhibitory immunoglobulin G receptors and their inositol lipid phosphatase effectors.

Authors:  Carol T Cady; Jeffrey S Rice; Vanessa L Ott; John C Cambier
Journal:  Immunol Rev       Date:  2008-08       Impact factor: 12.988

9.  Aberrant antibody affinity selection in SHIP-deficient B cells.

Authors:  Wai-Hang Leung; Tatiana Tarasenko; Zuzana Biesova; Hemanta Kole; Elizabeth R Walsh; Silvia Bolland
Journal:  Eur J Immunol       Date:  2012-12-12       Impact factor: 5.532

Review 10.  P66Shc: A Pleiotropic Regulator of B Cell Trafficking and a Gatekeeper in Chronic Lymphocytic Leukemia.

Authors:  Laura Patrussi; Nagaja Capitani; Cosima T Baldari
Journal:  Cancers (Basel)       Date:  2020-04-19       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.